Lung Cancers Not Yet Recruiting Phase 2 Trials for Osimertinib (DB09330)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02824952Neo-adjuvant Trial With AZD9291 in EGFRm+ Stage IIIA/B NSCLCTreatment